Remember meForgot password?
    Log in with Twitter
Press Release

Mettrum Health Announces Increase in Licensed Sales Capacity

TORONTO, ONTARIO--(Marketwired - Jan. 15, 2015) - Mettrum Health Corp. ("Mettrum" or "the Company") (TSX VENTURE:MT)(TSX VENTURE:MT.WT), a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of medical cannabis products, is pleased to announce that its wholly owned subsidiary, Mettrum Ltd., has been advised by Health Canada that its total licensed sales capacity under the Marihuana for Medical Purposes Regulations (Canada) (the "MMPR") has been amended to 1,200 kilograms per year of medical cannabis, from 650 kilograms per year. This increase allows Mettrum Ltd. to sell the medical cannabis grown at Agripharm Corp., another Mettrum Health Corp. company, which received a license under the MMPR on December 12, 2014 to grow 9,000 plants.

The Company is also pleased to report that, as a result, it has resumed its client acquisition and registration program. "We're excited to enter this next stage of Mettrum's growth. This amendment to our license will ensure we will have sufficient capacity for all existing and prospective customers going forward," said Michael Haines, CEO of Mettrum Health Corp.

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly-owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Marihuana for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "MMPR"), which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis on the same date at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Agripharm's facility in Clearview, Ontario. With the Company's two licenses, Mettrum is a leading producer and vendor of medical marijuana under the MMPR system.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations

Keelan Green
Media Relations
(613) 220-2016
Latest News
Top News